APOH

apolipoprotein H, the group of Apolipoproteins|Sushi domain containing

Basic information

Region (hg38): 17:66212033-66256525

Previous symbols: [ "B2G1" ]

Links

ENSG00000091583NCBI:350OMIM:138700HGNC:616Uniprot:P02749AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the APOH gene.

  • not_specified (24 variants)
  • not_provided (8 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the APOH gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000042.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
3
clinvar
3
missense
1
clinvar
23
clinvar
1
clinvar
2
clinvar
27
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
0
Total 0 1 23 1 5

Highest pathogenic variant AF is 6.840488e-7

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
APOHprotein_codingprotein_codingENST00000205948 844493
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.56e-150.0035412558701601257470.000636
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.2761821930.9440.00001032243
Missense in Polyphen6364.5270.97634746
Synonymous-0.2887672.91.040.00000426646
Loss of Function-0.6372118.11.160.00000104226

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007630.000762
Ashkenazi Jewish0.000.00
East Asian0.004300.00430
Finnish0.00004620.0000462
European (Non-Finnish)0.0002510.000246
Middle Eastern0.004300.00430
South Asian0.0009870.000980
Other0.0004910.000489

dbNSFP

Source: dbNSFP

Function
FUNCTION: Binds to various kinds of negatively charged substances such as heparin, phospholipids, and dextran sulfate. May prevent activation of the intrinsic blood coagulation cascade by binding to phospholipids on the surface of damaged cells.;
Pathway
Cholesterol metabolism - Homo sapiens (human);Platelet degranulation ;Response to elevated platelet cytosolic Ca2+;Platelet activation, signaling and aggregation;Hemostasis (Consensus)

Recessive Scores

pRec
0.650

Intolerance Scores

loftool
0.859
rvis_EVS
0.95
rvis_percentile_EVS
90.09

Haploinsufficiency Scores

pHI
0.269
hipred
N
hipred_score
0.281
ghis
0.878

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.996

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Apoh
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype;

Gene ontology

Biological process
negative regulation of endothelial cell proliferation;platelet degranulation;triglyceride metabolic process;blood coagulation, intrinsic pathway;negative regulation of endothelial cell migration;negative regulation of angiogenesis;positive regulation of blood coagulation;negative regulation of blood coagulation;plasminogen activation;negative regulation of myeloid cell apoptotic process;triglyceride transport;negative regulation of smooth muscle cell apoptotic process;positive regulation of lipoprotein lipase activity;regulation of fibrinolysis;negative regulation of fibrinolysis
Cellular component
extracellular region;extracellular space;cell surface;platelet dense granule lumen;very-low-density lipoprotein particle;high-density lipoprotein particle;chylomicron;collagen-containing extracellular matrix;extracellular exosome
Molecular function
protein binding;phospholipid binding;heparin binding;lipid binding;identical protein binding;lipoprotein lipase activator activity